Derek Hei brings to BlueRock over twenty years of experience developing breakthrough cell and gene therapies from research through clinical trials. He has distinct expertise in current Good Manufacturing Practices (cGMP) compliance, manufacturing, quality control testing and regulatory compliance. At BlueRock, he will oversee the entire manufacturing function, which includes developing and producing BlueRock’s induced pluripotent stem cell platform, maintaining its state-of-the-art cleanroom facility under cGMP, and leading the regulatory efforts for submitting an investigational new drug application. Dr. Hei also serves as an adjunct professor within the master of science in biotechnology program at UW-Madison where he instructs on aspects of biotherapeutic development including process development, scale-up, analytical methods development and key elements of Chemistry, Manufacturing and Control. Prior to joining BlueRock, Dr. Hei served as vice president of clinical manufacture, quality and regulatory at Cellular Dynamics International, where he oversaw the development and production of its cell therapy products. Prior, Dr. Hei served at Waisman Biomanufacturing, Cerus Corp and Genentech. Dr. Hei obtained his bachelor of science in chemical engineering from the University of Wisconsin-Madison, and his Ph.D. in biochemical engineering from the University of California, Berkeley.